NCT05259696 2025-08-20GLIMMER-01Palleon Pharmaceuticals, Inc.Phase 1/2 Completed69 enrolled 13 charts
NCT05864144 2025-08-15A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsSensei Biotherapeutics, Inc.Phase 1/2 Active not recruiting98 enrolled
NCT04291105 2025-03-26Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsVyriad, Inc.Phase 2 Recruiting87 enrolled